Recurrent visceral leishmaniasis in an immunocompetent patient: a case report

INTRODUCTION: Current treatment options for visceral leishmaniasis (pentavalent antimony, amphotericin B, liposomal amphotericin B and mitelfosine) achieve long-term clinical cure in the majority of immunocompetent patients. Disease relapse is usually provoked by T-cell number or function impairment...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lagadinou, Maria, Dimitropoulou, Dimitra, Assimakopoulos, Stelios F, Davoulos, George, Marangos, Markos
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601019/
https://ncbi.nlm.nih.gov/pubmed/23497385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-7-68
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars